Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) announced it has received a $15 million milestone payment from development and commercialization partner Braeburn ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments

Titan Pharma (TTNP) Will Present Four Post-Hoc Analyses from Probuphine Phase 3 in Opioid DependenceJune 15, 2016 7:06 AM Titan Pharmaceuticals Receives $15 Million Milestone Payment Following FDA Approval of Probuphine(R)June 13, 2016 7:00 AM